Afghanistan vs Mongolia: Access to anti-retroviral drugs, female
Afghanistan
38.0%
in 2024
Mongolia
36.0%
in 2024
Afghanistan rank
129th
Mongolia rank
130th
Access to anti-retroviral drugs, female over time
- Afghanistan
- Mongolia
How they compare
Afghanistan currently reports 38.0% against 36.0% in Mongolia, a difference of 2.0%.
That makes Afghanistan's figure about 1.1 times Mongolia's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Mongolia ahead.
Afghanistan ranks 129th and Mongolia ranks 130th of 141 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 1.2% | 1.1% | Mongolia |
| 2010s | 17.6% | 24.1% | 6.5% | Mongolia |
| 2020s | 33.8% | 38.8% | 5.0% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Afghanistan or Mongolia?
- Afghanistan, at 38.0% against 36.0% in Mongolia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Afghanistan and Mongolia?
- 2.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Mongolia?
- 25 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Mongolia rank globally for access to anti-retroviral drugs, female?
- Afghanistan ranks 129th and Mongolia ranks 130th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.